摘要:

Summary:Ninety‐eight dogs with previously untreated lymphosarcoma were selected for study. All dogs were clinically staged and stratified on the basis of stage. All dogs were treated with combination chemotherapy (vincristine, L‐as‐paragenase, cyclophosphamide, and methotrexate) and randomized to either a levamisole or placebo group. There was no significant difference in either remission time or survival time between the levamisole and placebo groups. Clinical stage, age, and body weight had no influence on remission or survival time. The most significant prognostic factor was sex: Female dogs had significantly enhanced remission time (p = 0.004) and survival time (p = <0.001).

ISSN:0732-6580    

出版商:OVID    

年代:1985

数据来源: OVID

ISSN:0732-6580    

出版商:OVID    

年代:1985

数据来源: OVID